NewsBenzingaProfound Medical Sees Q3 Sales $9.800M-$10.000M vs $6.934M Est Profound Medical Sees Q3 Sales $9.800M-$10.000M vs $6.934M Est Benzinga 2026.10.07 21:28 (GMT+0) Open on Benzinga Other news EYPT Stock Layoffs: What to Know About the Latest EyePoint Job Cuts Stocks Settle Higher as Chipmakers and AI-Infrastructure Stocks Rebound JP Morgan Maintains Overweight on First Solar, Lowers Price Target to $252 Karooooo Q2 Adj. EPS $0.57, Inline, Sales $100.292M Beat $97.720M Estimate Karooooo Affirms FY2027 GAAP EPS Guidance of $2.35-$2.44 vs $2.41 Est Lear Appoints Jared Fedele CFO, Effective March 1, 2027, Succeeding Jason Cardew
